Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial
about
Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
Impact of HACA on Immunomodula ...... ts from a SIOPEN Phase 2 Trial
@en
Impact of HACA on Immunomodula ...... ts from a SIOPEN Phase 2 Trial
@nl
type
label
Impact of HACA on Immunomodula ...... ts from a SIOPEN Phase 2 Trial
@en
Impact of HACA on Immunomodula ...... ts from a SIOPEN Phase 2 Trial
@nl
prefLabel
Impact of HACA on Immunomodula ...... ts from a SIOPEN Phase 2 Trial
@en
Impact of HACA on Immunomodula ...... ts from a SIOPEN Phase 2 Trial
@nl
P2093
P2860
P50
P356
P1433
P1476
Impact of HACA on Immunomodula ...... ts from a SIOPEN Phase 2 Trial
@en
P2093
Carla Manzitti
Dominique Valteau-Couanet
Hans Loibner
James Beck
Karoline Ehlert
Madlen Marx
Maxi Zumpe
Ruth Ladenstein
Shifra Ash
Thomas Klingebiel
P2860
P356
10.3390/CANCERS10100387
P407
P577
2018-10-17T00:00:00Z